Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 057873/0708 | |
| Pages: | 2 |
| | Recorded: | 10/20/2021 | | |
| Attorney Dkt #: | JAB7010USPCT2 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17431447
|
Filing Dt:
|
08/17/2021
|
|
Publication #:
|
|
Pub Dt:
|
04/28/2022
| | |
PCT #:
|
EP2020054485
|
|
Title:
|
CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE
|
|
|
Assignee
|
|
|
|
|
| 304 DOMINION CTR 43 QUEEN'S RD EAST |
| WANCHAI, CHINA |
|
|
Correspondence name and address
|
| |
JOSEPH F. SHIRTZ
|
| |
ONE JOHNSON & JOHNSON PLAZA
|
| |
NEW BRUNSWICK, NJ 08933
|
Search Results as of:
09/25/2024 12:01 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
